Hepatocyte growth factor treatment of prostate cancer DU145 cell line: time course
Summary:
Analysis of DU145 prostate cancer cells treated with hepatocyte growth factor (HGF) for up to 24 hrs. HGF receptor c-MET is specifically expressed in immature prostate cells. Results provide insight into the role of immature cells in prostate cancer by analysis of the HGF/c-MET pathway.
GPL570:
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Citation:
van Leenders GJ, Sookhlall R, Teubel WJ, de Ridder CM et al. Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS One 2011;6(11):e26753. PMID: 22110593
